Intrinsiqq
Stimcell Energetics Inc. logo

Stimcell Energetics Inc. Financials

STME

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 17 available years
Income Statement
TTM
MAY 2026
MAY 2025
MAY 2024
MAY 2023
MAY 2022
Revenues
Revenue$0––$0$0–
Cost of Revenue–––––$0
Gross Profit$0––$0$0$0
General & Administrative$0$0$0$0$0$0
Research & Development––––$0$0
Total Operating Expenses$1$1$1$0$0$1
Operating Income-$0––-$0-$0-$0
Non-Operating
Net Interest Expense-$0-$0-$0-$0-$0-$0
Other Non-Operating Income (Expense)-$0$0$0$0$0$0
Net Income
Net Income-$0-$1-$1-$0-$0-$1
EPS (Basic)-$0.09-$0.04-$0.03-$0.01-$0.15-$0.15
Weighted Avg Shares (Basic)220.9M20.7M19.8M161.0M62.9M62.8M

Stimcell Energetics (STME) financials: revenue, profit and margins

Stimcell Energetics (STME) generated about n/a in revenue and -$799,291.00 in net income over the trailing twelve months, growing at roughly -57.7% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Stimcell Energetics profitable?+

Stimcell Energetics reported about -$799,291.00 in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is Stimcell Energetics growing?+

Stimcell Energetics's revenue has compounded at roughly -57.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside STME's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 14 Oct 2026, covering the period ending 31 Aug 2026, as reported to the SEC. Data last refreshed 15 Oct 2026. How this is calculated.

Fiscal year ends May.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with STME

CompareIntrinsic value
DRORDror Ortho-Design Inc.
$0.00+0.00%40
YBGJYubo International Biotech Limited
$0.01+0.00%10

Spot a number that looks wrong? Check it in STME's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing STME

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.